SCHEMBL7002580

SCHEMBL7002580

c1cnc2nc(Cc3nc4ncccc4[nH]3)[nH]c2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.58
METAP1 P53582 2/20 0.51
METAP2 P50579 1/20 0.51
CYP2C9 P11712 1/20 0.51
NOS1 P29475 1/20 0.51
NOS2 P35228 1/20 0.51
DRD4 P21917 1/20 0.49
TP53 P04637 4/20 0.49
PDE5A O76074 3/20 0.47
HPGD P15428 3/20 0.46
AURKA O14965 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
NPSR1 Q6W5P4 1/20 0.45
POLB P06746 1/20 0.45
TPH1 P17752 1/20 0.44
TPH2 Q8IWU9 1/20 0.44
ALDH1A1 P00352 1/20 0.44
BACE1 P56817 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6994149 0.90 GAA (0.58) NUDT1DRD4TP53SMN1; SMN2NPC1
SCHEMBL8806229 0.88 GAA (0.60) NUDT1METAP1METAP2DRD4TP53
SCHEMBL2314765 0.85 DDAH1 (0.55) NUDT1METAP1METAP2CYP2C9NOS1
SCHEMBL31587712 0.85 NUDT1 (0.55) NUDT1METAP1METAP2CYP2C9NOS1
SCHEMBL4773954 0.85 NUDT1 (0.59) NUDT1METAP1METAP2CYP2C9NOS1
SCHEMBL4347800 0.85 NUDT1 (0.55) NUDT1METAP1METAP2CYP2C9NOS1
SCHEMBL3967813 0.85 NUDT1 (0.55) NUDT1METAP1METAP2CYP2C9NOS1
SCHEMBL6216010 0.85 NUDT1 (0.55) NUDT1METAP1METAP2CYP2C9NOS1
SCHEMBL6948805 0.84 PKM (0.57) NUDT1METAP1METAP2CYP2C9NOS1
Hydrochloric Acid SCHEMBL5864683 0.83 NUDT1 (0.53) NUDT1METAP1METAP2CYP2C9NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6541486-B1 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. ELAN PHARMA INTERNATIONAL LTD. (IE) 2003-04-01 US claimed
EP-1189889-B1 COMPOSITIONS AND METHODS FOR INHIBITING CELL DEATH ELAN PHARMA INT LTD (IE) 2003-12-17 EP disclosed
US-6541486-B1 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. ELAN PHARMA INTERNATIONAL LTD. (IE) 2003-04-01 US disclosed